US equities |
MU $928.76 ▲+0.00% SNDK $1,304.84 ▲+0.00% SKHY $145.36 ▲+0.00% TSLA $407.46 ▲+0.00% NVDA $217.94 ▲+0.00% INTC $93.74 ▲+0.00% SPCX $148.58 ▲+0.00% STX $667.85 ▲+0.00%
FinancialContent

Latest News about Lophos Pharma

Recent news which mentions Lophos Pharma

Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
Tickers CCC NEWS
Tags Lophos Pharma Markets Benzinga
From Benzinga
Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression
Tags Benzinga Psychedelic Capital Conference Markets Lophos Pharma
From Benzinga
G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma
Tags Greenridez 2/0 Acquisitions Corp peyote M&A
From Benzinga